Condition detail

Multiple Myeloma

Multiple Myeloma is a blood cancer condition tracked with diagnosis details, symptoms, labs, treatments, side effects, infection precautions, imaging, and oncology plans.

Blood / immune ID 158
Multiple Myeloma reference image: An anatomical illustration of red blood cells.
Image: Blausen 0761 RedBloodCells.png by BruceBlaus, CC BY 3.0.
Common Tracking

Track CBC results, bleeding or bruising, fatigue, infections, triggers, exposures, medicines, transfusions, and specialist follow-up.

Connected records

Database matches for this condition

Palpitations reference image: An anatomical illustration of the human heart.
Image: Blausen 0451 Heart Anterior.png by Blausen Medical Communications, Inc., CC BY 3.0.

Palpitations

Palpitations is a heart, blood vessel, or circulation-related symptom that may be useful to track with pulse, blood pressure, swelling, exertion, and medication timing.

Cardiovascular Heart / circulation
Cold intolerance reference image: A person jogging outdoors.
Image: Jogging Woman in Grass.jpg by Mike Baird, CC BY 2.0.

Cold intolerance

Cold intolerance is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.

General / systemic Whole body
Excessive sweating reference image: A person jogging outdoors.
Image: Jogging Woman in Grass.jpg by Mike Baird, CC BY 2.0.

Excessive sweating

Excessive sweating is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.

General / systemic Whole body
Fatigue reference image: A person jogging outdoors.
Image: Jogging Woman in Grass.jpg by Mike Baird, CC BY 2.0.

Fatigue

Fatigue is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.

General / systemic Whole body
General weakness reference image: A person jogging outdoors.
Image: Jogging Woman in Grass.jpg by Mike Baird, CC BY 2.0.

General weakness

General weakness is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.

General / systemic Whole body
Heat intolerance reference image: A person jogging outdoors.
Image: Jogging Woman in Grass.jpg by Mike Baird, CC BY 2.0.

Heat intolerance

Heat intolerance is a body-wide symptom or change that can be useful to track alongside temperature, hydration, sleep, medicines, and recent exposures.

General / systemic Whole body
Unintentional weight changes reference image: An anatomical illustration of adipose tissue.
Image: Blausen 0012 AdiposeTissue.png by BruceBlaus, CC BY 3.0.

Unintentional weight changes

Unintentional weight changes is a metabolism, hormone, or blood-sugar-related symptom that may be tracked with food intake, glucose readings, medicines, hydration, and energy changes.

Metabolic / endocrine Hormones / metabolism
Bone pain reference image: An anatomical illustration of the knee joint.
Image: Blausen 0596 KneeAnatomy Front.png by BruceBlaus, CC BY 3.0.

Bone pain

Bone pain is a muscle, joint, bone, or movement-related symptom that may be tracked with location, activity, injury, swelling, stiffness, and function.

Musculoskeletal Bones / joints / muscles
Falls reference image: An anatomical illustration of the knee joint.
Image: Blausen 0596 KneeAnatomy Front.png by BruceBlaus, CC BY 3.0.

Falls

Falls is a muscle, joint, bone, or movement-related symptom that may be tracked with location, activity, injury, swelling, stiffness, and function.

Musculoskeletal Bones / joints / muscles
Muscle weakness reference image: An anatomical illustration of the knee joint.
Image: Blausen 0596 KneeAnatomy Front.png by BruceBlaus, CC BY 3.0.

Muscle weakness

Muscle weakness is a muscle, joint, bone, or movement-related symptom that may be tracked with location, activity, injury, swelling, stiffness, and function.

Musculoskeletal Bones / joints / muscles
bortezomib reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.

Bortezomib

Used for: Bortezomib for injection is a proteasome inhibitor indicated for: • treatment of adult patients with multiple myeloma ( 1.1 ) • treatment of adult patients with mantle cell lymphoma ( 1.2 ) 1.1 Multiple Myeloma Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma. 1.2 Mantle Cell Lymphoma Bortezomib for injection is indicated for the treatment of adult patients with mantle cell lymphoma.

Imported medicine concept
ixazomib reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.

Ixazomib

Used for: NINLARO ® is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

Official label medicine
pomalidomide reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.

Pomalidomide

Used for: Pomalidomide capsules are a thalidomide analogue indicated for the treatment of adult patients: in combination with dexamethasone, for patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy ( 1.1 ). with AIDS-related Kaposi sarcoma (KS) after failure of highly active antiretroviral therapy (HAART) or in patients with KS who are HIV-negative.

Endocrine medicine
zoledronic acid reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.

Zoledronic acid

Used for: Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy. (1.1) Patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy.

Bone health medicine